John Saewook M.D. Kauh - Apr 17, 2025 Form 4 Insider Report for Tvardi Therapeutics, Inc. (TVRD)

Role
Chief Medical Officer
Signature
/s/ Dan Conn, Attorney-in-Fact
Stock symbol
TVRD
Transactions as of
Apr 17, 2025
Transactions value $
$0
Form type
4
Date filed
4/21/2025, 05:15 PM
Previous filing
Apr 17, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TVRD Employee Stock Option (right to buy) Award $0 +36.2K $0.00 36.2K Apr 17, 2025 Common Stock 36.2K $17.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.